Chapter 24 Benign vulval disease
Infections
Fungal
Candida albicans
• predisposed groups: newborns, females between puberty and menopause, postmenopausal women on hormone replacement therapy (HRT), women with diabetes mellitus
Non-infectious dermatoses
Contact/allergic dermatitis
• may be triggered by local irritants (e.g. perfumes, soaps, fabric softeners, detergents, feminine sprays, urine, pads and panty liners, toilet paper); drugs; topical creams; latex in condoms
• examination may reveal vulval erythema and/or swelling; fissuring in the interlabial sulci may occur
• important to avoid the trigger and other irritants such as perfumes, soaps, fabric softener, nylon underwear, tight clothing, excessive pad/panty liner use, toilet paper with fragrance
Lichen sclerosus
• can occur at any age, but is most common in postmenopausal women in whom it is a chronic condition
• sites of occurrence include the vulva, perineum and perianal area (spares the labia majora and vagina)
• the condition alters the vulval architecture resulting in atrophy (resorption of labia minora, phimosis of clitoral hood, introital stenosis, fissuring of the fourchette and/or vestibule during intercourse)
• malignant potential: 1%–4% risk of vulval squamous cell carcinoma (if adequately managed risk is reduced)
• histology reveals homogenised collagen in the upper dermis; basal layer vacuolar degeneration and lymphocytic inflammatory infiltrate; acanthosis of the epidermis
Management
• Topical steroid therapy can be used for symptoms and to slow the progression of anatomical distortion.
• Treatment starts with potent topical steroids (e.g. betamethasone dipropionate; mometasone furoate 0.1%) and may move to mid-strength topical steroids for maintenance (e.g. betamethasone valerate 0.02%; triamcinolone acetonide).
Lichen planus
Lichen simplex chronicus (LSC)
• the condition may have commenced due to a pruritic process (e.g. allergic reactions, fungal infection)
Vulvodynia
• genital dyaesthesia described as pain, burning, stinging and irritation in the absence of visible findings or identified disease of the vulva or vagina
• neuropathic pain: increased concentration of nerve endings in the vestibule have been demonstrated
• may be triggered by: infection (recurrent candidiasis, herpes simplex virus, human papillomavirus), vulval laser or diathermy, trauma, vaginal surgery
• on examination with a Q-tip swab, one can find tenderness over the vestibular glands and vestibule (which may be erythematous)
• exclusion of candidiasis is imperative; if candidiasis is present, treat with long-term oral antifungals
• a biopsy is only indicated if there is suspicion of other vulval pathology (e.g. lichen sclerosus, vulval intraepithelial neoplasia)
• management involves a multidisciplinary approach: physiotherapy, psychologist (biofeedback), psychosexual counselling, pain management, support groups
Dennerstein G., Scurry J., Brenan J., Allen D. The vulva and vagina manual. Melbourne: Gynederm Publishing; 2005.
Farage M., Galask R. Vulvar vestibulitis syndrome: a review. National Vulvodynia Association News, USA. 2006. Winter
Goldstein A. Dermatological diseases of the vulval. USA: National Vulvodynia Association News; 2006. Summer